AQUESTIVE THERAPEUTICS INC. - COMMON STOCK
4.8300
13-November-24 15:45:00
15 minutes delayed
Stocks
-0.1600
-3.21%
Today's range
4.8150 - 5.1400
ISIN
N/A
Source
NASDAQ
-
25 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
12 Apr 2024 15:01:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
01 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
25 Mar 2024 07:00:25 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
19 Mar 2024 20:49:43 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
19 Mar 2024 15:01:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
05 Mar 2024 16:05:49 By Nasdaq GlobeNewswire
-
21 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
15 Feb 2024 07:00:35 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference
30 Jan 2024 07:00:27 By Nasdaq GlobeNewswire
-
05 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
06 Nov 2023 15:37:36 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Completes $45 Million Debt Refinancing
02 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
31 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Provides Business Update
09 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reaffirms Timeline and Pathway for Anaphylm™ (epinephrine) Sublingual Film
20 Sep 2023 08:04:50 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
23 Aug 2023 07:00:42 By Nasdaq GlobeNewswire